SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* U.S. Healthcare I, L.L.C. (Last) (First) (Middle) 375 PARK AVENUE, 12TH FLOOR (Street) NEW YORK NY 10152 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 11/17/2010	3. Issuer Name and Ticker or Trading Symbol KV PHARMACEUTICAL CO /DE/ [ KV.A ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrant	11/17/2010	11/17/2015	Class A Common Stock	9,900,000	$1.62	I	See footnote(1)
Warrant	11/30/2010	11/17/2015	Class A Common Stock	2,687,511	$1.62	I	See footnote(1)

1. Name and Address of Reporting Person* U.S. Healthcare I, L.L.C. (Last) (First) (Middle) 375 PARK AVENUE, 12TH FLOOR (Street) NEW YORK NY 10152 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Centerbridge Partners Holdings, LLC (Last) (First) (Middle) 375 PARK AVENUE, 12TH FLOOR (Street) NEW YORK NY 10152 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Centerbridge Credit Advisors, L.L.C. (Last) (First) (Middle) 375 PARK AVENUE, 12TH FLOOR (Street) NEW YORK NY 10152 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Centerbridge Special Credit Advisors, L.L.C. (Last) (First) (Middle) 375 PARK AVENUE, 12TH FLOOR (Street) NEW YORK NY 10152 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* U.S. Healthcare II, L.L.C. (Last) (First) (Middle) 375 PARK AVENUE, 12TH FLOOR (Street) NEW YORK NY 10152 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Aronson Jeffrey (Last) (First) (Middle) 375 PARK AVENUE, 12TH FLOOR (Street) NEW YORK NY 10152 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Gallogly Mark T (Last) (First) (Middle) 375 PARK AVENUE, 12TH FLOOR (Street) NEW YORK NY 10152 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Centerbridge Partners, L.P. (Last) (First) (Middle) 375 PARK AVENUE, 12TH FLOOR (Street) NEW YORK NY 10152 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

Explanation of Responses:

1. The securities reported herein are held directly by each of U.S. Healthcare I, L.L.C. ("USH I") and U.S. Healthcare II, L.L.C. ("USH II"). Centerbridge Partners Holdings, LLC ("CPH") is the general partner of Centerbridge Partners, L.P. ("CP"), which is the managing member of each of Centerbridge Credit Advisors, L.L.C. ("CCA") and Centerbridge Special Credit Advisors, L.L.C. ("CSCA"). CCA and CSCA are the investment managers of each of USH I and USH II, respectively, with respect to which each has voting and dispositive authority over the securities reported herein. Messrs. Aronson and Gallogly are the managing members of CPH. Therefore, CPH, CP, CCA , CSCA and Messrs. Aronson and Gallogly may be deemed to be the beneficial owners of the securities reported herein. Each of CPH, CP, CCA , CSCA and Messrs. Aronson and Gallogly disclaims beneficial ownership of such securities except to the extent of his or its pecuniary interest therein.

Remarks:

	CENTERBRIDGE PARTNERS, L.P., By: Centerbridge Partners Holdings, LLC, its general partner, /s/ Jeffrey H. Aronson, Managing Member	11/29/2010
	CENTERBRIDGE PARTNERS HOLDINGS, LLC, /s/ Jeffrey H. Aronson, Managing Member	11/29/2010
	CENTERBRIDGE CREDIT ADVISORS, L.L.C., By: Centerbridge Partners, L.P., its managing member,By: Centerbridge Partners Holdings, LLC, its general partner, /s/ Jeffrey H. Aronson, Managing Member	11/29/2010
	CENTERBRIDGE SPECIAL CREDIT ADVISORS, L.L.C., By: Centerbridge Partners, L.P., its managing member, By: Centerbridge Partners Holdings, LLC, its general partner, /s/ Jeffrey H. Aronson, Managing Member	11/29/2010
	U.S. HEALTHCARE I, L.L.C., By: Centerbridge Credit Advisors, L.L.C., its manager, By: Centerbridge Partners, L.P., its managing member, By: Centerbridge Partners Holdings, LLC, its general partner, /s/ Jeffrey H. Aronson, Managing Member	11/29/2010
	U.S. HEALTHCARE II, L.L.C., By: Centerbridge Special Credit Advisors, L.L.C., its manager, By: Centerbridge Partners, L.P., its managing member, By: Centerbridge Partners Holdings, LLC, its general partner, /s/ Jeffrey H. Aronson, Managing Member	11/29/2010
	JEFFREY H. ARONSON, /s/ Jeffrey H. Aronson	11/29/2010
	MARK T. GALLOGLY, /s/ Mark T. Gallogly	11/29/2010
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.